Services
Opioid Medications used in Treatment
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
Assessment/Pre-treatment
- Outreach to persons in the community
- Comprehensive substance use assessment
- Screening for substance use
- Interim services for clients
Type of Care
Treatment Approaches
- Brief intervention
- Relapse prevention
- Telemedicine/telehealth therapy
Special Programs/Groups Offered
- Clients who have experienced sexual abuse
- Clients with HIV or AIDS
- Adult women
- Adult men
- Clients with co-occurring mental and substance use disorders
- Criminal justice (other than DUI/DWI)/Forensic clients
- Clients with co-occurring pain and substance use disorders
- Seniors or older adults
- Clients who have experienced trauma
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Veterans
- Clients who have experienced intimate partner violence, domestic violence
- Pregnant/postpartum women
Payment/Insurance/Funding Accepted
Facility Operation (e.g., Private, Public)
- Private for-profit organization
Testing
- Testing for Hepatitis C (HCV)
- Drug and alcohol oral fluid testing
- HIV testing
- Drug or alcohol urine screening
Education and Counseling Services
- Individual counseling
- Substance use disorder education
- Group counseling
Type of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder
Type of Opioid Treatment
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Buprenorphine maintenance
- Prescribes naltrexone
Age Groups Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
- Other contracted prescribing entity
- No formal relationship with prescribing entity
Pharmacotherapies
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Naltrexone (extended-release, injectable)
- Naltrexone (oral)
- Clonidine
Facility Smoking Policy
- Smoking permitted in designated area
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
- Outpatient
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Intensive outpatient treatment
Facility Vaping Policy
- Vaping permitted in designated area
Transitional Services
- Aftercare/continuing care
- Naloxone and overdose education
- Outcome follow-up after discharge
Gender Accepted
Location
408 West Main Street, Ottawa, IL 61350
Phone: (866) 453-5835
Website: http://brightsideclinic.com
← All programs in Ottawa
315 East McKinley Road, Ottawa, IL
727 East Etna Road, Ottawa, IL
218 West Madison Street, Ottawa, IL